- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr. Colin Cooke Highlights Healthcare Reform's Effects on Pulmonary Medicine
Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI, says that hospitals with higher readmission rates that treat patients with acute myocardial infarction, congestive heart failure, and pneumonia will be penalized due to healthcare reform.
Colin Cooke, MD, MSc, Assistant Professor of Medicine, University of Michigan, Ann Arbor, MI, says that hospitals with higher readmission rates that treat patients with acute myocardial infarction, congestive heart failure, and pneumonia will be penalized due to healthcare reform. In 2015, chronic obtrusive pulmonary disease (COPD) will be added to the list of conditions measured. However, there is less evidence underlying readmissions in COPD. Dr Cooke notes that more research is needed regarding readmissions in COPD since it will be affected by the Affordable Care Act.
This video was taken on May 19, 2013, at the ATS 2013 International Conference in Philadelphia, PA.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
